Does it matter when drugs are taken?

Hypertension

Volumn 54, Issue 1, 2009, Pages 23-24

  Morgan, Trefor Owen ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; PERINDOPRIL; RAMIPRIL; TRANDOLAPRIL;

BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; DOSAGE SCHEDULE COMPARISON; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; DRUG EFFECT; DRUG HALF LIFE; DRUG MECHANISM; EVENING DOSAGE; HUMAN; HYPERTENSION; MORNING DOSAGE; NONHUMAN; NOTE; PRIORITY JOURNAL; STROKE; SYMPATHETIC TONE; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; DRUG CHRONOTHERAPY; HUMANS; HYPERTENSION; RAMIPRIL; TIME FACTORS; TREATMENT OUTCOME;

EID: 67649848157     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.131912     Document Type: Note

References (10)

1. Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama Study. Hypertension. 2005;45:240-245.
2. Morgan TO, Brunner HR, Aubert J-F, Wang Q, Griffiths C, Delbridge L. Cardiac hypertrophy depends upon sleep blood pressure: a study in rats. J Hypertens. 2000;18:445-451.
3. Brandenberger G, Follenius M, Goichot B, Saini J, Ehrhart J, Simon C. Twenty-four-hour profiles of plasma renin activity in relation to the sleep awake cycle. Hypertension. 1994;12:277-283.
4. Morgan TO, Anderson A. Different drug classes have variable effects on blood pressure depending on the time of day. Am J Hypertens. 2003;16: 46-50.
5. Hermida RC, Ayala DE. Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing. Hypertension. 2009;54:40-46.
6. Morgan T, Anderson A, Jones E. The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J Hypertens. 1997;15:205-211.
7. Smith DHG, Neutel JM, Black HR, Schoenberger JA, Weber MA. Once daily therapy with trandolapril in the treatment of hypertension. J Hum Hypertens. 1996;10:129-134.
8. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study investigators. N Engl J Med. 2000;342:145-153.
9. PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet. 2001;358:1033-1041.
10. Fox KM, European Trial on Reduction of Cardiac Events With Perindopril in Stable Coronary Artery Disease investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomized, double-blind, placebo-controlled, multicentre trial (the EUROPA Study). Lancet. 2003;362:782-788.